Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis

Neurology

Volumn 85, Issue 1, 2015, Pages 18-28

  Absinta, Martina ^a,b   Vuolo, Luisa ^a,c   Rao, Anuradha ^a   Nair, Govind ^a   Sati, Pascal ^a   Cortese, Irene C M ^a   Ohayon, Joan ^a   Fenton, Kaylan ^a   Reyes Mantilla, María I ^c   Maric, Dragan ^a   Calabresi, Peter A ^c   Butman, John A ^d   Pardo, Carlos A ^c   Reich, Daniel S ^a,e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; GADOLINIUM;

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX LESION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LEPTOMENINGEAL INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MENINX DISORDER; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SINGLE DRUG DOSE; COMPLICATION; MENINGITIS; MENINX; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; PROCEDURES;

GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGES; MENINGITIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 84937010544     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001587     Document Type: Article

References (35)

1. Rocca MA, Messina R, Filippi M. Multiple sclerosis imaging: recent advances. J Neurol 2013; 260: 929-935
2. Kutzelnigg A, Lassmann H. Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 2014; 122: 15-58
3. Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 2013; 262: 1-10
4. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365: 2188-2197
5. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14: 164-174
6. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130: 1089-1104
7. Magliozzi R, Howell OW, Reeves C, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-493
8. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011; 134: 2755-2771
9. Choi SR, Howell OW, Carassiti D, et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain 2012; 135: 2925-2937
10. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-669
11. Sormani MP, Bruzzi P. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-Analysis of randomised trials. Lancet Neurol 2013; 12: 669-676
12. Mamourian AC, Hoopes PJ, Lewis LD. Visualization of intravenously administered contrast material in the CSF on fluid-Attenuated inversion-recovery MR images: an in vitro and animal-model investigation. AJNR Am J Neuroradiol 2000; 21: 105-111
13. Griffiths PD, Coley SC, Romanowski CA, Hodgson T, Wilkinson ID. Contrast-enhanced fluid-Attenuated inversion recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol 2003; 24: 719-723
14. Parmar H, Sitoh YY, Anand P, Chua V, Hui F. Contrastenhanced FLAIR imaging in the evaluation of infectious leptomeningeal diseases. Eur J Radiol 2006; 58: 89-95
15. Fukuoka H, Hirai T, Okuda T, et al. Comparison of the added value of contrast-enhanced 3D fluid-Attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. AJNR Am J Neuroradiol 2010; 31: 868-873
16. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: gadolinium-enhanced fast fluid-Attenuated inversion-recovery MR imaging. Radiology 1999; 211: 257-263
17. Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006; 355: 581-592
18. Sibley CH, Plass N, Snow J, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three-And five-year outcomes. Arthritis Rheum 2012; 64: 2375-2386
19. Bagnato F. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-Attenuated inversion recovery images in the presence of gadolinium contrast agent. J Neuroimaging 2009; 19: 201-204
20. Kataoka H, Taoka T, Ueno S. Early contrast-enhanced magnetic resonance imaging with fluid-Attenuated inversion recovery in multiple sclerosis. J Neuroimaging 2009; 19: 246-249
21. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302
22. Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C. Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2. J Magn Reson Imaging 2012; 35: 537-542
23. Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 2010; 49: 1524-1535
24. Absinta M, Nair G, Filippi M, et al. Postmortem magnetic resonance imaging to guide the pathologic cut: individualized, 3-dimensionally printed cutting boxes for fixed brains. J Neuropathol Exp Neurol 2014; 73: 780-788
25. Daams M, Geurts JJ, Barkhof F. Cortical imaging in multiple sclerosis: recent findings and grand challenges. Curr Opin Neurol 2013; 26: 345-352
26. Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302-308
27. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6: 205-217
28. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of no better explanation. Lancet Neurol 2006; 5: 841-852
29. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008; 14: 1157-1174
30. OMahony J, Bar-Or A, Arnold DL, et al. Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program. J Child Neurol 2013; 28: 184-197
31. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688
32. Hawker K, OConnor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009; 66: 460-471
33. Naismith RT, Piccio L, Lyons JA, et al. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology 2010; 74: 1860-1867
34. Kappos L, Li D, Calabresi PA, et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011; 378: 1779-1787
35. Bar-Or A, Calabresi PA, Arnold D, et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, openlabel, phase I trial. Ann Neurol 2008; 63: 395-400